http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-182432-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69c91bbf0395db010b4806f50d808c4e
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D455-00
filingDate 1978-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9bd313d852a9f2625cfac050363f2bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52c201fd4a2314a529451b07a5ee3826
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f27161fc949293bd9ec7ee2536305ec8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41e04ade255a6d664a98b2011345b48f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cb3729b65365bcb045a0eea5415c2ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47ce47223b27bfb76b237dc27cb6e14c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71852dbd12d8e0d35992e7aa0aa1adac
publicationDate 1984-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HU-182432-B
titleOfInvention Process for producing new 9-halogeno-1-alkyl-1-alkyloxycarbonylethyl-oktahydro-indoloquinolysines
abstract The present invention relates to novel racemic and optically active 9-halo-1-alkyl-1-alkyloxycarbonylethyl octahydroindolokinolysis of formulas Va and Vb, wherein R2 and R3 are C1-C4 alkyl, X is halogen and is pharmaceutically acceptable. for the preparation of their acid addition salts by selectively reducing the novel Va and Vb after converting the novel 9-halo-1-alkyl-1-alkoxycarbonylethylhexahydro-indolokinolizinium alkoxide of formula IVa, if desired, to the acid addition salt of formula IVb. 9-halo-1-alkyl-1-alkyloxycarbonylethyloctahydroindolokinolysine isomer is separated into isomers, or hydrolysed first, and the resulting carboxylic acid isomer is separated into isomers, and each isomer is then esterified and, if desired, racemic Va or Vb obtained by any of the above methods The compound of formula (nos) is resolved and / or converted into a pharmaceutically acceptable acid addition salt. The importance of the novel 9-halo-1-alkyl-1-alkyloxycarbonylethyl-octahydroindoloquinolizines of formula Va and Vb and their acid addition salts is an important intermediate of the 10-halo-vincamic acid esters with valuable therapeutic properties, which in the old age are cerebral vessels. are particularly suitable for the treatment of behavioral disorders caused by damage and calcification. fif 20 25 30 182432 Αθ H R30r-CH2-CH2-x1x2 R2 IVb -1-
priorityDate 1978-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414867059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419575732
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20722760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451363760
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9548687
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18177619
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527252
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475145
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3826051
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28123
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448233682
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1550213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416130041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453782864
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164181712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453611334
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530544
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523446
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6554
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411555350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6362
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546506
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530548
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448899743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21893726
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559577
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449355117
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6340
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9550
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559499
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22892188

Total number of triples: 59.